Ege Universitesi Hastanesi

Bornova, İzmir 35100

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Dyslipidemias, Heart Failure, Heart Failure With Preserved Ejection Fraction, Hyperlipoproteinemia, Lipid Metabolism Disorders, Metabolic Diseases, Metastatic Non-Small Cell Lung Cancer, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF) — Stopped early
• A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) — Running, not enrolling
• A Study of LY3561774 in Participants With Mixed Dyslipidemia — Completed